p21 is necessary for the beneficial effects of fasting during chemotherapy
Cancer Commun (Lond)
.
2023 Jan;43(1):164-168.
doi: 10.1002/cac2.12384.
Epub 2022 Nov 4.
Authors
Adrián Plaza
1
,
Andrés Pastor-Fernández
1
,
José L López-Aceituno
1
,
Marta Barradas
1
,
Cristina Pantoja
1
,
Pablo J Fernandez-Marcos
1
Affiliation
1
Metabolic Syndrome Group (BIOPROMET), Madrid Institute for Advanced Studies (IMDEA) Food, CEI UAM+CSIC, Madrid, E28049, Spain.
PMID:
36331275
PMCID:
PMC9859726
DOI:
10.1002/cac2.12384
No abstract available
Publication types
Letter
MeSH terms
Biomarkers, Tumor
Fasting*
Humans
Neoplasms* / drug therapy
Oncogene Protein p21(ras)*
Substances
Biomarkers, Tumor
Oncogene Protein p21(ras)